Unpredictable response to vasodilator therapy in primary pulmonary hypertension

International Journal of Clinical Pharmacology and Therapeutics

Volumn 36, Issue 8, 1998, Pages 435-440

  Schmiedt, M I ^a,b   Shettigar, U R ^a   Siddique, M ^a   Barbier, G ^a   Bialow, M ^a   Carranza, S ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Florida College   (United States)

Author keywords

Isoproterenol; Primary pulmonary hypertension

Indexed keywords

ISOPRENALINE; VASODILATOR AGENT;

ADULT; ARTICLE; AUTOPSY; BRADYCARDIA; CASE REPORT; HEART OUTPUT; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG VASCULAR RESISTANCE; MALE; PULMONARY HYPERTENSION; TREATMENT OUTCOME;

BRADYCARDIA; FATAL OUTCOME; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; INFUSIONS, INTRAVENOUS; ISOPROTERENOL; LUNG; MALE; MIDDLE AGED; VASODILATOR AGENTS;

EID: 0031853357     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Berkenboom G 1982 Failure of nifedipine therapy in primary pulmonary hypertension. Br Heart J 47: 511
2. Burchenal J, Loscalzo J 1994 Endothelial dysfunction and pulmonary hypertension. Prim Cardiol 20: 28-32
3. Christman B et al 1992 An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 327: 70-75
4. Connally C et al 1997 Valvular heart disease associated with fenfluramine-phentermine. NEJM 337: 581-588
5. Elkayam U 1978 Unfavorable hemodynamic and clinical effect of isoproterenol in primary pulmonary hypertension. Cardiovasc Med 3: 1177-1180
6. Fisher J et al 1984 Hemodynamic effects of nifedipine versus hydralazine in primary pulmonary hypertension. Am J Cardiol 54: 646-650
7. Fuster V et al 1984 Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 70: 580-587
8. Galie N et al 1995 Role of pharmacological tests in the treatment of primary pulmonary hypertension. Am J Cardiol 75: 55A-62A
9. Groves B et al 1985 A comparison of the acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertension. Am Heart J 110: 1200-1204
10. Lee D, Roveti G, Ross R 1963 The hemodynamic effects of isoproterenol on pulmonary hypertension in man. Am Heart J 65: 361-367
11. Loyd J et al 1984 Familial primary pulmonary hypertension: clinical patterns. Am Rev Respir Dis 129: 194-197
12. Melmon K, Braunwald E 1963 Familial pulmonary hypertension. N Engl J Med 269: 770-775
13. Meyrick B, Reid L 1979 Development of pulmonary arterial changes in rats fed Crotalaria spectabilis. Am J Pathol 94: 37-50
14. Olivari M et al 1984 Hemodynamic effects of nifedipine at rest and during exercise in primary pulmonary hypertension. Chest 86: 14-19
15. Packer M et al 1984 Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease. J Am Coll Cardiol 4: 890-901
16. Packer M 1982 Deleterious effects of hydralazine in patients with primary pulmonary hypertension. N Engl J Med 306: 1326-1331
17. Palevski H 1989 Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents. Circulation 80: 1207-1221
18. Panza J et al 1990 Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323: 22-27
19. Pearl R et al 1983 Acute hemodynamic effects of nitroglycerin in pulmonary hypertension. Ann Int Med 99: 9-13
20. Pepke-Zaba J et al 1991 Inhaled nitric oxide as a cause of selective pulmonary hypertension. Lancet 338: 1173-1174
21. Rich S et al 1983 Comparative actions of hydralazine, nifedipine, and amrinone in primary pulmonary hypertension. Am J Cardiol 52: 1104-1107
22. Rich S et al 1987 Primary pulmonary hypertension. A national prospective study. Ann Int Med 107: 216-223
23. Rich S, Brundage B 1987 High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. Circulation 76: 135-141
24. Rich S 1995 Medical treatment of primary pulmonary hypertension: A bridge to transplantation? Am J Cardiol 75: 63A-66A
25. Rubin L et al 1983 Treatment of primary pulmonary hypertension with nifedipine. A hemodynamic and scintigraphic evaluation. Ann Int Med 99: 433-438
26. Rubin L 1993 ACCP Consensus statement. Primary pulmonary hypertension. Chest 104: 236-250
27. Shettigar U et al 1976 Primary pulmonary hypertension. Favorable effect of isoproterenol. N Engl J Med 295: 1414-1415
28. Stewart D et al 1991 Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Int Med 114: 464-469
29. Suarez L et al 1979 Long-term follow-up in primary pulmonary hypertension. Br Heart J 41: 702-708
30. Weir K et al 1989 The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension. Am Rev Respir Dis 140: 1623-1630